Skip to content

ThOracoscopic Wedge Resection Treated With Chest Tube Removal Intraoperatively

Pain and Reasons for Hospitalization in Patients Treated Without Post-operative Chest Tube After Thoracoscopic Wedge Resection - A Randomized Controlled Study

Status
Terminated
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02829736
Acronym
TOTTI
Enrollment
25
Registered
2016-07-12
Start date
2016-09-01
Completion date
2017-08-01
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Decreased Lung Function, Delayed Discharge, Pain

Keywords

lung neoplasm, lung metastasis, enhanced recovery after surgery, fast-track surgery, intraoperative chest tube removal, pain, lung function, reasons for admission

Brief summary

Chest tubes are used routinely although preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal. Previous studies are however either retrospective or mainly concerning benign disease. Hypothesis: Participants treated without post-operative chest tube after thoracoscopic wedge resection have less pain, better pulmonary function and similar complication profile than participants treated with standard post-operative chest tube, and could possibly be discharged earlier.

Interventions

PROCEDUREIntraoperative sealing test

A standard 28 Fr chest tube is inserted through the anterior port hole and all port holes are closed. With the tip of the chest tube below water, the pleura is emptied from air during continuous ventilation of the lungs. An air leak after 5 minutes of ventilation indicates a negative sealing test, whereas a cessation of air leak within 5 minutes indicates a positive sealing test.

PROCEDUREStandard post-operative chest tube

A regular chest tube is left in the pleura.

PROCEDUREIntraoperative chest tube removal

Chest tube is removed intraoperatively.

Sponsors

Rigshospitalet, Denmark
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Masking description

Randomization occurs after ended surgery, thus masking allocation to the personnel and participant. After Randomization, there is no masking.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Elective thoracoscopic wedge resection * Speaks and understands Danish * FEV1 \>= 60% of expected

Exclusion criteria

* Increased risk of air leak evaluated by surgeon (large adhesions, bullae, emphysema, deep resection, etc.) * Increased risk of bleeding evaluated by surgeon (high INR, anticoagulation not paused, large bleeding, etc.) * Air leak on intraoperative sealing test * Patients previously included in study * Planned intraoperative frozen section with possible lobectomy * Previously included in current study * Planned frozen section diagnostics * Previous ipsilateral anatomic lung resection

Design outcomes

Primary

MeasureTime frameDescription
Pain on NRSThrough post-operative admission, an average of 1 day.Differences in pain between the two groups.

Secondary

MeasureTime frameDescription
Reasons for post-operative admissionThrough post-operative admission, an average of 1 day.Daily evaluation of reasons for admission.
Lung functionUp to post-operative day 1.FEV1 measured preoperatively and on post-operative day 1 at 8 am.
Reinsertion of chest tubesUp to post-operative day 30.Frequency of chest tube reinsertion.
PneumothoraxUp to post-operative day 1.Size and frequency of pneumothorax on x-ray after removal of chest tube
ComplicationsUp to post-operative day 30.Surgical complications including mortality.

Countries

Denmark

Contacts

STUDY_DIRECTORHenrik J. Hansen, MD

Rigshospitalet, Denmark

STUDY_DIRECTORRené H. Petersen, MD

Rigshospitalet, Denmark

STUDY_DIRECTORHenrik Kehlet, DMSc

Rigshospitalet, Denmark

PRINCIPAL_INVESTIGATORBo L. Holbek, MD

Rigshospitalet, Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026